Dan Furman explains why the biggest opportunity in neurotechnology may not be new hardware, but the software layer that can decode brain signals in real time and make them useful across health, education, entertainment, and human-computer interaction.

Todd Langevin explains how BIOTRONIK Neuro is bringing remote care into spinal cord stimulation, giving clinicians clearer visibility into therapy usage, device performance, and the issues that can affect long-term patient outcomes.

Rebecca Crane explains why Quality in neurotech is not just about compliance, but a practical advantage that helps startups reduce risk, move with more clarity, and build products that work in the real world.

A non-surgical brain–computer interface built with nanoparticles. Tetiana Aleksandrova, Founder & CEO of Subsense, shares how her team is aiming for invasive-level accuracy without surgery and why she believes BCIs will become one of the biggest technology revolutions of our lifetime.

A deeply personal journey into neurotechnology. Ben LeNail shares how living with a rare neurological disease shaped his work as an advisor across biotech and neurotech — and why the future of brain health depends on turning data into meaningful, real-world impact.

Smell is the brain’s fastest pathway to emotion and memory — yet it remains one of the most overlooked signals in neurotechnology. In this interview, Lekha Challappa, co-founder of Aurat Aroma, explains how olfactory intelligence can be quantified, modelled, and used to predict human perception. From flavour and fragrance to healthcare and threat detection, she shares why digitised scent could become a critical layer in the future of neurotech and AI.

Discover how Spinally founder and CEO Pawel Soluch is pioneering a new intrathecal neural interface, FuturaLead™, designed to enable safer, more precise recording and stimulation directly from the spinal cord. In this interview, he shares insights on the future of spinal neurotechnology, the challenges of translating science into surgical reality, and what’s next for restoring function through minimally invasive neuromodulation.

Omari Bouknight, CEO of Resonant Link Medical, shares how his team is building the wireless backbone for the next generation of implantable devices — from neurostimulation and BCI to cardiac care. In this exclusive interview, he discusses the company’s journey, the Orion platform’s core innovations, and what it takes to bring high-performance power and data transfer into the body.